Cytokinetics Inc. buy Royal Bank of Canada
Start price
11.11.25
/
50%
€55.50
Target price
11.11.26
€75.30
Performance (%)
1.80%
Price
10:37
€56.50
Summary
This prediction is currently active. With a performance of 1.80%, the BUY prediction by Royal_Bank_of_Canada for Cytokinetics Inc. is trending in the right direction. This prediction currently runs until 11.11.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Cytokinetics Inc. | -2.564% |
| iShares Core DAX® | 1.330% |
| iShares Nasdaq 100 | 1.099% |
| iShares Nikkei 225® | 1.265% |
| iShares S&P 500 | 1.000% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Royal Bank Of Canada from $82.00 to $87.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat